January 1, 1970 (Vol. , No. )

John Sterling Editor in Chief Genetic Engineering & Biotechnology News

The current pharma model aimed at blockbuster sales is a disservice to patients, according to Marc-Andre Gagnon, an economist at York University. In this issue of GEN, Gagnon reveals top pharmaceutical firms to be among the best brand-management firms with increasingly stealth advertising campaigns. He also acknowledges that said business model is quite profitable. What do you think about this dichotomy?

Previous articleDutch Center and GeneGo to Collaborate on Toxicity Testing
Next articleCHDI to Provide $37M to Evotec in Collaboration Extension